ESOPAug 3, 2026, 05:02 PM
Zentalis Grants 84,000 Stock Options to New Employees
AI Summary
Zentalis Pharmaceuticals announced that its Compensation Committee granted non-qualified stock options to purchase an aggregate of 84,000 shares of common stock to two newly hired employees. These options were issued under the 2022 Employment Inducement Incentive Award Plan, in accordance with Nasdaq Listing Rule 5635(c)(4), as an inducement for their employment. The exercise price is $4.65 per share, and the options will vest over four years.
Key Highlights
- Zentalis granted non-qualified stock options for 84,000 shares.
- Options were granted to two newly hired employees.
- The exercise price is $4.65 per share, matching the closing price on grant date.
- Options were granted under the 2022 Employment Inducement Incentive Award Plan.
- The stock options have a 10-year term and vest over four years.
- Vesting includes 25% on the first anniversary and 75% in equal monthly installments over three years thereafter.
Price Impact
More from ZNTL